Literature DB >> 25881673

Association of bioimpedance spectroscopy-based volume estimation with postdialysis hypotension in patients receiving hemodialysis.

Adrian P Abreo1, Glenn M Chertow2, Lorien S Dalrymple3, George A Kaysen3,4, Kirsten L Johansen5,6,7.   

Abstract

Clinical examination to determine the dry weight of patients on hemodialysis (HD) has been problematic, with studies showing discordance between physician assessment and objective measures of volume status.We studied the association between predialysis bioimpedance spectroscopy (BIS)-based estimates of fluid overload and postdialysis hypotension in 635 patients in the United States Renal Data System ACTIVE/ADIPOSE (A Cohort study To Investigate the Value of Exercise/Analyses Designed to Investigate the Paradox of Obesity and Survival in ESRD) study receiving HD in 2009-2011. We recorded predialysis and postdialysis weight and blood pressures over 3 consecutive HD sessions and performed BIS before a single session. Using a previously reported method of estimating normohydration weight, we estimated postdialysis fluid overload (FOpost ) in liters. We used logistic regression with extracellular water/total body water (ECW/TBW) or estimated FOpost as the primary predictor and 1 or more postdialysis systolic blood pressures less than 110 mmHg as the dependent variable. Models were adjusted for age, sex, race, ultrafiltration rate per kilogram of body weight, end-stage renal disease vintage, diabetes mellitus, heart failure, and albumin. Higher ECW/TBW was associated with lower odds of postdialysis hypotension (odds ratio [OR] 0.35, 95% confidence interval [CI] 0.15-0.84 per 0.1, P = 0.02). Every liter of FOpost was associated with lower adjusted odds of postdialysis hypotension (OR 0.86, 95% CI 0.79-0.95, P = 0.003). Prospective studies are needed to determine whether this application of BIS could improve current clinical efforts to minimize episodes of postdialysis hypotension without leading to volume overload.
© 2015 International Society for Hemodialysis.

Entities:  

Keywords:  Bioimpedance spectroscopy; end-stage renal disease; hemodialysis; volume status

Mesh:

Year:  2015        PMID: 25881673      PMCID: PMC4778547          DOI: 10.1111/hdi.12305

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  25 in total

1.  Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial.

Authors:  Donal N Reddan; Lynda Anne Szczech; Vic Hasselblad; Edmund G Lowrie; Robert M Lindsay; Jonathan Himmelfarb; Robert D Toto; John Stivelman; James F Winchester; Linda A Zillman; Robert M Califf; William F Owen
Journal:  J Am Soc Nephrol       Date:  2005-06-01       Impact factor: 10.121

2.  A whole-body model to distinguish excess fluid from the hydration of major body tissues.

Authors:  Paul W Chamney; Peter Wabel; Ulrich M Moissl; Manfred J Müller; Anja Bosy-Westphal; Oliver Korth; Nigel J Fuller
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

3.  Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line.

Authors:  Hector J Rodriguez; Regina Domenici; Anne Diroll; Irina Goykhman
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

4.  Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients.

Authors:  F K Port; T E Hulbert-Shearon; R A Wolfe; W E Bloembergen; T A Golper; L Y Agodoa; E W Young
Journal:  Am J Kidney Dis       Date:  1999-03       Impact factor: 8.860

5.  Volume sensitivity of blood pressure in end-stage renal disease.

Authors:  J E Ventura; M Spósito
Journal:  Nephrol Dial Transplant       Date:  1997-03       Impact factor: 5.992

6.  Whole-body and thoracic bioimpedance measurement: hypertension and hyperhydration in hemodialysis patients.

Authors:  L Nescolarde; P Bogónez; J Calpe; R Hernández; T Doñate; J Rosell
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2007

7.  Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow.

Authors:  Christopher W McIntyre; James O Burton; Nicholas M Selby; Lucia Leccisotti; Shvan Korsheed; Christopher S R Baker; Paolo G Camici
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-14       Impact factor: 8.237

8.  Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate.

Authors:  Nicholas M Selby; James O Burton; Lindsay J Chesterton; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 8.237

9.  Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial.

Authors:  Rajiv Agarwal; Pooneh Alborzi; Sangeetha Satyan; Robert P Light
Journal:  Hypertension       Date:  2009-01-19       Impact factor: 10.190

10.  Bioimpedance-guided fluid management in hemodialysis patients.

Authors:  Ulrich Moissl; Marta Arias-Guillén; Peter Wabel; Néstor Fontseré; Montserrat Carrera; José Maria Campistol; Francisco Maduell
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-15       Impact factor: 8.237

View more
  4 in total

Review 1.  Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis.

Authors:  Peter Noel Van Buren
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

2.  Assessing Extracellular Volume in Hemodialysis Patients Using Intradialytic Blood Pressure Slopes.

Authors:  Hao Liu; Rong Lu; Shani Shastri; Mark Sonderman; Peter Noel Van Buren
Journal:  Nephron       Date:  2018-02-13       Impact factor: 2.847

3.  Extracellular Volume Overload and Increased Vasoconstriction in Patients With Recurrent Intradialytic Hypertension.

Authors:  Peter Noel Van Buren; Yunyun Zhou; Javier A Neyra; Guanghua Xiao; Wanpen Vongpatanasin; Jula Inrig; Robert Toto
Journal:  Kidney Blood Press Res       Date:  2016-11-11       Impact factor: 2.687

4.  Extracellular water/total body water ratio as predictor of mortality in hemodialysis patients.

Authors:  Rosa Pérez-Morales; Javier Donate-Correa; Ernesto Martín-Núñez; Nayra Pérez-Delgado; Carla Ferri; Aurora López-Montes; Alejandro Jiménez-Sosa; Juan Francisco Navarro-González
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.